tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN

Newron Pharmaceuticals SpA (NWRN) Revenue

Compare
0 Followers

Newron Pharmaceuticals SpA Revenue

Newron Pharmaceuticals SpA had a revenue of 3.41M in the quarter ending Jun 30, 2024, with -4.38%. This bring the company's revenue in the last twelve months to 6.97M, Increased -23.04%. In the fiscal year ending Dec 31, 2023, Newron Pharmaceuticals SpA had annual revenue of 9.06M with 48.62% growth.
Revenue (ttm)
6.97M
Revenue Growth
450.19%
P/S Ratio
18.09
Revenue/Employee
CHF411,682
Employees
22
Market Cap
CHF163.86M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20239.06M2.96M+48.62%
Dec 31, 20226.09M332.00K+5.76%
Dec 31, 20215.76M504.00K+9.59%
Dec 31, 20205.26M-1.78M-25.29%
Dec 31, 20197.04M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis